PARTNER Cohort A 30-day and one-year mortality
Thirty-day mortality was superior in the TAVI group but one-year mortality was similar, demonstrating noninferiority of TAVI compared with operative AVR.
![Mayo Clinic [logo]](/images-global/mayo_stacked.png)
Thirty-day mortality was superior in the TAVI group but one-year mortality was similar, demonstrating noninferiority of TAVI compared with operative AVR.